Placental GH, IGF-I, IGF-binding protein-1, and leptin during a glucose challenge test in pregnant women: Relation with maternal body weight, glucose tolerance, and birth weight

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 6, 2002, Pages 2875-2882

  Verhaeghe, Johan ^a,e   Pintiaux, Axelle ^b   Van Herck, Erik ^c   Hennen, Georges ^d   Foidart, Jean Michel ^a   Igout, Ahmed ^b  

^a Department of Obstetrics and Gynecology ^*  (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c Centre Hospitalier de la Citadelle   (Belgium)

^d UNIVERSITY OF LIÈGE   (Belgium)

^e UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; LEPTIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C;

ADULT; ARTICLE; BIRTH WEIGHT; FEMALE; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HORMONE DETERMINATION; HUMAN; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MATERNAL CARE; MATERNAL SERUM; MULTIPLE REGRESSION; PLACENTA WEIGHT; PREDICTION; PREGNANCY; PRIORITY JOURNAL; SAMPLING;

EID: 0036077792     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.6.8569     Document Type: Article

References (47)

1. A tincture of time does not turn the tide. Type 2 diabetes trends in offspring of type 2 diabetic mothers
2. Fetal growth and placental function
3. Placental growth hormone as a potential regulator of maternal IGF-I during human pregnancy
4. Placental growth hormone levels in normal pregnancy and in pregnancies with intrauterine growth retardation
5. Radioimmunoassay of placental protein 12: Levels in amniotic fluid, cord blood, and serum of healthy adults, pregnant women, and patients with trophoblastic disease
6. Purification and assay of insulin-like growth factor-binding protein-1: Measurement of circulating levels throughout pregnancy
7. Insulin-like growth factor binding protein-1: Recent findings and new directions
8. Leptm levels in pregnancy: Marker for fat accumulation and mobilization?
9. Leptin production and release in the dually in vitro perfused human placenta
10. Regulation of maternal IGF-I by placental GH in normal and abnormal pregnancies
11. Growth hormone, insulin-like growth factor I and its binding proteins 1 and 3 in last trimester intrauterine growth retardation with increased pulsatility index in the umbilical artery
12. A prospective study of maternal serum insulin-like growth factor-I in pregnancies with appropriately grown or growth restricted fetuses
13. The role of insulin-like growth factor binding protein-1 phosphoisoforms in pregnancies with impaired placental function identified by Doppler ultrasound
14. Placental growth hormone (GH), GH-binding protein, and insulin-like growth factor axis in normal, growth-retarded, and diabetic pregnancies: Correlations with fetal growth
15. Insulin-like growth factor-binding protein-1, glucose tolerance and fetal growth in human pregnancy
16. Circulating levels of IGF-I and IGF-binding protein-1 throughout pregnancy: Relation to birthweight and maternal weight
17. Phosphorylated insulin-like growth factor binding protein 1 is increased in pregnant diabetic subjects
18. Leptin and maternal growth during adolescent pregnancy
19. Increased plasma leptin in gestational diabetes
20. Relationships between the uterine environment and maternal plasma concentrations of insulin-like growth factor binding protein-1 and placental protein 14 in early pregnancy
21. Relationship between various maternal body mass measurements and size of the newborn
22. Clinical practice recommendations 2000
23. Of pregnancy and progeny
24. Insulin resistance in acromegaly: Defects in both hepatic and extrahepatic insulin action
25. Effects of growth hormone on insulin action in man. Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization
26. Glucose inhibits placental GH secretion in vitro
27. Insulin-like growth factor-binding protein-1 modulates blood glucose levels
28. Dysregulation of the insulin/IGF binding protein-1 axis in transgenic mice is associated with hyperinsulinemia and glucose intolerance
29. The classification and definition of the hypertensive disorders of pregnancy
30. Standaarden van geboortegewicht-voor-zwangerschapsduur voor de Vlaamse boreling
31. Assessment of fetal growth
32. Immunoassay of endogenous plasma insulin in man
33. Purification and biochemical characterization of recombinant human placental growth hormone produced in Escherichia coli
34. The human placental growth hormone variant: A review
35. Placental growth hormone and IGF-I in a pregnant woman with Pit-1 deficiency
36. Influence of age, sex, and insulin on osteoblast function: Osteoblast dysfunction in diabetes mellitus
37. IGF-I, IGF-II, IGF binding protein 1, and C-peptide in second trimester amniotic fluid are dependent on gestational age but do not predict weight at birth
38. Impact of time since last meal on the gestational glucose challenge test
39. Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man
40. Relationships between placental GH concentration and maternal smoking, newborn gender, and maternal leptin: Implications for birth weight
41. Placental protein 12 (PP12): Factors affecting levels in late pregnancy
42. Growth hormone modulates insulin regulation of hepatic insulin-like growth factor binding protein-1 transcription
43. Synchronicity of frequently sampled, 24-h concentrations of circulating leptin, luteinizing hormone, and estradiol in healthy women
44. Circulating insulin concentrations, smoking, and alcohol intake are important independent predictors of leptin in young healthy men
45. Leptin and variables of body adiposity, energy balance, and insulin resistance in a population-based study. The Hoorn study
46. Fasting insulin levels influence plasma leptin levels independently from the contribution of adiposity: Evidence from both a cross-sectional and an intervention study